Insider trades
Sessa Capital, Director of SAB Biotherapeutics SABS, has filed 0 purchases and 3 sales on the open market. The latest trade was on 25/09/29.
Sessa Capital
Director
- Company
- SAB Biotherapeutics SABS
- First filing
- 23/01/20
- Trades
- 29 trades
- Buys / sales
- 0 / 3
- 12-month net buying
- No record
- Last trade
- 25/09/29
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 24/03/06 | 24/03/06 | 10,000,000 sh | $9.00 | $90,000,000 | −39.6% | |
| Open-market sale | 23/04/14 | 23/04/18 | 2,190,549 sh | $24.32 | $53,274,151.68 | −12.3% | |
| Open-market sale | 23/01/18 | 23/01/20 | 3,000,000 sh | $9.40 | $28,200,000 | −20.2% |
